K. Von Both

The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series

K. Ardeshna, R. Hough, L. Menezes, 2021, British journal of haematology.

Brentuximab vedotin plus bendamustine in relapsed and refractory classical Hodgkin lymphoma in children, adolescents and young adults: a single centre experience

P. Humphries, S. Daw, R. Shah, 2020 .